Language
Country/Area
No result found
Behind the rapid weight gain: How does ROHHAD affect children's lives?
In the field of child health, there is a rare disease that is attracting great attention from the medical community, that is, the syndrome of rapid weight gain accompanied by hypothalamic dysfunction, hypoventilation, and autonomic nervous system dysfunction (ROHHAD). The cause of the disease remains unknown, and its effects can be fatal in growing children.
ROHHAD mainly affects the endocrine system and autonomic nervous system, but symptoms vary widely, making diagnosis more complicated.
Main symptoms
The first obvious sign of ROHHAD is usually rapid weight gain, which usually occurs between the ages of 1.5 and 11 years. As weight increases, many children experience increased appetite and rapid weight gain. In addition, as the disease progresses, respiratory system-related problems such as hypoventilation also arise.
Approximately 40% of patients with ROHHAD will develop neuroendocrine tumors, although these tumors are not thought to significantly affect patient prognosis.
Diagnosis process
Due to the diversity and rarity of ROHHAD symptoms, many patients may be misdiagnosed with other diseases, such as Cushing's disease or congenital central hypoventilation syndrome, during the early stages of diagnosis. Early identification of symptoms is critical to reducing risk and improving treatment outcomes.
The mortality rate of ROHHAD reaches 50% to 60% in undiagnosed and untreated cases, mainly due to cardiopulmonary arrest caused by untreated hypoventilation.
Affects all aspects of life
For ROHHAD patients, in addition to physical challenges, the psychological and social impacts cannot be ignored. Some affected children may develop behavioral problems or intellectual disabilities, which are thought to be caused by low oxygen, especially if the condition is not treated promptly.
Treatment Options
At present, there is no cure for ROHHAD, and it mainly focuses on the management of patient symptoms. Each patient's treatment plan will vary depending on the presenting symptoms. For the treatment of hypoventilation, patients usually need to use respiratory support equipment, such as BiPAP machines. Some severely ill patients may need a tracheotomy to support breathing.
As caregivers of ROHHAD patients, parents and medical staff need to closely monitor the patient's oxygen levels and overall health to prevent possible complications.
Future directions and research
Internationally, clinical trials for ROHHAD are already underway, which is crucial to the understanding and management of the disease. As the medical community further explores this symptom, more effective treatment options and supportive therapies may be found in the future.
As the understanding of ROHHAD deepens, will more children be able to receive diagnosis and treatment in time, thereby improving their quality of life?
